Literature DB >> 15866430

Neurologic complications associated with respiratory syncytial virus.

Laura L Sweetman1, Yu-tze Ng, Ian J Butler, John B Bodensteiner.   

Abstract

Encephalopathy has been demonstrated to be associated with respiratory syncytial virus bronchiolitis. In this study, the data on all patients less than 14 years of age hospitalized with respiratory syncytial virus bronchiolitis over the past 4 years was reviewed. Patients who had concomitant diagnoses consistent with neurologic disease underwent detailed chart review. There were 964 patients (age 0.1 to 13.6 years) with a diagnosis of respiratory syncytial virus bronchiolitis. Thirty-six of these patients had concurrent neurologic diagnoses. Twenty-four patients were excluded because of preexistent neurologic disorders, probable simple febrile seizures, or a history of epilepsy. Twelve respiratory syncytial virus-positive patients had definite neurologic complications without another recognized cause. Seven of these patients had seizures (predominantly generalized tonic-clonic and one with status epilepticus), three had generalized encephalopathy (marked hypotonia and decreased responsiveness) of whom two also developed esotropia. Two patients developed isolated esotropia. There was an incidence of neurologic complications of 1.2% (0.7% seizures) in a total of 964 patients with respiratory syncytial virus bronchiolitis. This percentage does not include presumed simple febrile seizures or exacerbations of preexisting seizure disorder (further 1.3%). Neurologic complications occur with respiratory syncytial virus bronchiolitis, and physicians and other caregivers should be aware of this entity as well as the favorable prognosis.

Entities:  

Mesh:

Year:  2005        PMID: 15866430     DOI: 10.1016/j.pediatrneurol.2005.01.010

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  26 in total

1.  Impaired learning resulting from respiratory syncytial virus infection.

Authors:  Janyra A Espinoza; Karen Bohmwald; Pablo F Céspedes; Roberto S Gómez; Sebastián A Riquelme; Claudia M Cortés; Javier A Valenzuela; Rodrigo A Sandoval; Floria C Pancetti; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

2.  Respiratory syncytial virus-related encephalitis: magnetic resonance imaging findings with diffusion-weighted study.

Authors:  Arim Park; Sang-il Suh; Gyu-Ri Son; Young Hen Lee; Hyung Suk Seo; Baik-Lin Eun; Nam-Joon Lee; Hae-Young Seol
Journal:  Neuroradiology       Date:  2013-12-13       Impact factor: 2.804

Review 3.  A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus.

Authors:  Emma Rey-Jurado; Jorge Soto; Nicolás Gálvez; Alexis M Kalergis
Journal:  Hum Vaccin Immunother       Date:  2017-06-09       Impact factor: 3.452

Review 4.  Biomarkers of respiratory syncytial virus (RSV) infection: specific neutrophil and cytokine levels provide increased accuracy in predicting disease severity.

Authors:  Paul M Brown; Dana L Schneeberger; Giovanni Piedimonte
Journal:  Paediatr Respir Rev       Date:  2015-05-23       Impact factor: 2.726

5.  Occurrence and risk factors associated with seizures in infants with severe bronchiolitis.

Authors:  Annabelle Huguet; Frederic Valla; Joseph Toulouse; Etienne Javouhey; Florent Baudin
Journal:  Eur J Pediatr       Date:  2021-04-12       Impact factor: 3.183

6.  A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus.

Authors:  Fabián E Díaz; Mariana Guerra-Maupome; Paiton O McDonald; Daniela Rivera-Pérez; Alexis M Kalergis; Jodi L McGill
Journal:  Front Immunol       Date:  2021-04-26       Impact factor: 7.561

Review 7.  Think outside the box: extrapulmonary manifestations of severe respiratory syncytial virus infection.

Authors:  Kentigern Thorburn; C Anthony Hart
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

Review 8.  Extrapulmonary manifestations of severe respiratory syncytial virus infection--a systematic review.

Authors:  Michael Eisenhut
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

Review 9.  Functional Impairment of Mononuclear Phagocyte System by the Human Respiratory Syncytial Virus.

Authors:  Karen Bohmwald; Janyra A Espinoza; Raúl A Pulgar; Evelyn L Jara; Alexis M Kalergis
Journal:  Front Immunol       Date:  2017-11-27       Impact factor: 7.561

10.  Mild encephalitis/encephalopathy with a reversible splenial lesion associated with respiratory syncytial virus infection in infants.

Authors:  Xue-Lin Li; Jinming Han; Zhong-Rui Yan; Bing-Wei Zhang; Hai-Yang Wang
Journal:  J Neurovirol       Date:  2021-07-05       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.